-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Janux Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q2 2024.
- Janux Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.96M, a 66% increase year-over-year.
- Janux Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$44M, a 35% increase year-over-year.
- Janux Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$58.3M, a 7.56% increase from 2022.
- Janux Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63.1M, a 93% decline from 2021.
- Janux Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$32.7M, a 382% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)